Quantum Pharma conditionally raises £15m in accelerated bookbuild
20th Oct 2016 11:35
(ShareCast News) - Quantum Pharma confirms its accelerated bookbuild to raise up to £15m has closed successfully, subject to the passing of certain resolutions by shareholders at the company's annual meeting. The company, which noted that it continued to trade in line, believed net proceeds would re
Read moreQuantum Pharma's shares plummet as it expects to perform below expectations in H2
4th Oct 2016 09:10
(ShareCast News) - Shares in AIM-listed drug manufacturer Quantum Pharma plunged nearly 50% on Tuesday morning as it said it expects the performance in the second half of the year to be "materially below market expectations" although it anticipates "strong" growth. Chief financial officer and acting
Read moreQuantum Pharma looks to meet FY market expectations
31st Aug 2016 11:48
(ShareCast News) - Quantum Pharma has made good progress during its first half, in line with management views, and anticipates meeting market expectations for the full year. "As previously indicated, the group's performance for the year is second-half weighted and will be dependent on the level of s
Read moreQuantum Pharma completes Mucodis range with vaginal cream
5th Aug 2016 12:03
(ShareCast News) - Niche pharmaceutical developer Quantum Pharma announced on Friday that its subsidiary Colonis has launched Mucodis vaginal cream. The AIM-traded company said the cream is part of the Mucodis range of in-licensed patented medical devices, which focus on treating some of the side ef
Read moreQuantum Pharma launches Mucodis Rectal Gel
26th Jul 2016 12:00
(ShareCast News) - Quantum Pharma said Colonis has launched its Mucodis Rectal Gel for preventing and treating rectal mucositis, a common side effect of chemotherapy and radiotherapy in cancer patients. Mucositis is a condition characterised by pain and inflammation of the body's mucous membranes wh
Read moreQuantum Pharma CEO Scaife steps down, trading in line
12th Jul 2016 13:41
(ShareCast News) - Quantum Pharma chief executive Andrew Scaife has stepped down after seven years but is leaving the company with current trading running in line with management expectations. Scaife has decided to leave the Newcastle-upon-Tyne company due to family reasons but has agreed to stay un
Read moreQuantum Pharma launches third product from its Mucodis range of treatments
11th Jul 2016 15:47
(ShareCast News) - Quantum Pharma launched the third product of its Mucodis range for the treatment of some of the side effects suffered by patients undergoing cancer treatment. Mucodis dermal spray, which reached markets on Monday, was targetted at treating radiation-induced dermatitis, a condition
Read moreQuantum Pharma promotes Chris Rigg to CFO
8th Mar 2016 12:37
(ShareCast News) - AIM-listed niche pharmaceutical manufacturer Quantum Pharma has promoted Chris Rigg to the role of chief financial officer. The appointment follows the resignation of Martin Such on 7 March. Rigg joined Quantum as the company's strategic director in November 2015 and has been
Read moreQuantum Pharma seeks solace after profit warning
19th Jan 2016 09:18
(ShareCast News) - Quantum Pharma, the manufacturer and supplier of niche medicines and healthcare services, warned annual profits would be lower than forecast due to pipeline delays that will also affect the coming financial year. Despite making significant progress in the year, with a restructure
Read moreQuantum Pharma surges as subsidiary signs out-licensing deal
12th Oct 2015 10:42
(ShareCast News) - Quantum Pharma shares surged on Monday after it said its subsidiary Colonis Pharma has signed an out-licensing deal with a major German pharmaceutical group. The Kent-based group has granted its new partner exclusive licence to secure the marketing authorisation required to use Co
Read moreQuantum Pharma on line to meet full-year expectations
20th Aug 2015 10:02
(ShareCast News) - Pharmaceutical manufacturer Quantum Pharma said it expects to meet its annual targets, although it revealed some of its licence applications are taking longer than expected. The London-listed company said it has completed the takeover of Lamda and NuPharm Group and expects both ac
Read moreQuantum Pharma completes NuPharm acqusition
14th Jul 2015 09:34
(ShareCast News) - Pharmaceutical manufacturer and developer Quantum Pharma has completed the acquisition of NuPharm in a deal worth up to £13.3m. The group said it will pay £9.34m in cash upon completion of the deal with up to an additional £4m potentially payable under earn-out agreements. In a s
Read moreSunday share tips: Lloyds Banking, Quindell, Quantum Pharmaceutical
31st May 2015 16:40
Lloyds Banking Group shares are a 'hold', said Questor in the Sunday Telegraph. The bank is certainly making progress: reporting rising profits, is close to returning to paying a dividends and small investors will soon able to take advantage of the accelerated sale of the government's shareholding.
Read moreQuantum Pharma completes Lamda takeover
17th Apr 2015 10:32
Pharmacy and hospital supplier Quantum Pharma has agreed a €9.7m (£7m) deal to acquire pharmaceutical development company Lamda. Under the agreement, the County-Durham based group will take control of 100% of the share capital of Lamda (UK) Ltd, Lamda Laboratories SA and Lamda Pharmaceuticals SA, wh
Read more